Myelofibrosis after essential thrombocythemia complicated by alveolar proteinosis

Leuk Lymphoma. 2003 Jun;44(6):1049-52. doi: 10.1080/1042819031000063453.

Abstract

Hematological diseases are often accompanied by respiratory disorders. Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by excessive accumulation of surfactant in the alveolar space. We describe a case of PAP complicated by myelofibrosis following essential thrombocythemia. The patient developed high fever, respiratory failure, and leuko-erythroblastosis during the progressive course of PAP. These symptoms were alleviated by prednisolone. The level of serum IL-6 was elevated when PAP was progressing rapidly. This may explain why the symptoms were alleviated by the steroids.

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow / pathology
  • Fatal Outcome
  • Female
  • Humans
  • Lung / pathology
  • Middle Aged
  • Prednisone / therapeutic use
  • Primary Myelofibrosis / complications
  • Primary Myelofibrosis / diagnosis*
  • Primary Myelofibrosis / diagnostic imaging
  • Primary Myelofibrosis / pathology
  • Pulmonary Alveolar Proteinosis / complications*
  • Pulmonary Alveolar Proteinosis / diagnostic imaging
  • Pulmonary Alveolar Proteinosis / pathology
  • Thrombocythemia, Essential / etiology*
  • Thrombocythemia, Essential / pathology
  • Tomography, X-Ray Computed

Substances

  • Prednisone